Search - tctmd.com

Displaying 261 - 278 of 278

Sort: Relevancy | Date

News Daily News

Synopsis of New Hypertension Guidelines Renews Concerns and Controversy

L.A. McKeown

January 22, 2018

News Daily News

New Guideline Aims to Standardize Anticoagulation During Cardiopulmonary Bypass

Todd Neale

January 19, 2018

News Daily News

High Rate of Clinical Events at 6 Months for Ischemic CVD Patients

Michael O'Riordan

January 19, 2018

News Daily News

‘Nontraditional’ CAC, CRP, or ABI Risk Tools Not Recommended, Says USPSTF

Shelley Wood

January 17, 2018

News Daily News

Medtronic’s Riptide System Cleared for Thrombus Aspiration in Acute Stroke

Todd Neale

January 16, 2018

News Daily News

Cardiac Rehab Rates Still Low in Medicare and VA Populations

L.A. McKeown

January 09, 2018

News Daily News

Role of Lp(a) Still to Be Determined, but NHLBI Sees a Path Forward

Michael O'Riordan

January 09, 2018

News Daily News

Further Calls to Update Guidelines for PFO Closure in Stroke Prevention

Yael L. Maxwell

January 08, 2018

News Daily News

Heart Failure Risk Following 'Silent' MI Warrants Scrutiny: ARIC Analysis

Caitlin E. Cox

January 08, 2018

News Daily News

Penumbra Separator 3D: Another Brick in the Wall Supporting Aspiration for Acute Stroke

Todd Neale

January 08, 2018

News Daily News

De-escalating DAPT to a Clopidogrel-Based Strategy After PCI for ACS Gets Boost in TOPIC-VASP

Yael L. Maxwell

January 04, 2018

News Daily News

Registry Challenges LVEF Cutoff for AVR, With Implications for Asymptomatic Patients

L.A. McKeown

January 04, 2018

News Daily News

Ten Principles for Successful Treatment of HF With Reduced EF: New ACC Decision Pathway

Michael O'Riordan

January 02, 2018

News Daily News

The Biggest News of 2017: TCTMD’s Top 10

Shelley Wood

January 01, 2018

Presentation ISCTR 2016

Current Challenges to and Future Direction of US Early Feasibility Studies FDA Point of View

Presenter: Andrew Farb

October 28, 2016

CME

Role of Interventional Cardiologists in Secondary Prevention of Acute Coronary Syndromes: Redefining Clinical Practice

Partner Content

Tricuspid Valve Therapy & Innovative Clinical Trials: A Comprehensive Discussion

May 16, 2018

CME

Advertisement

Synopsis of New Hypertension Guidelines Renews Concerns and Controversy

New Guideline Aims to Standardize Anticoagulation During Cardiopulmonary Bypass

High Rate of Clinical Events at 6 Months for Ischemic CVD Patients

‘Nontraditional’ CAC, CRP, or ABI Risk Tools Not Recommended, Says USPSTF

Medtronic’s Riptide System Cleared for Thrombus Aspiration in Acute Stroke

Cardiac Rehab Rates Still Low in Medicare and VA Populations

Role of Lp(a) Still to Be Determined, but NHLBI Sees a Path Forward

Further Calls to Update Guidelines for PFO Closure in Stroke Prevention

Heart Failure Risk Following 'Silent' MI Warrants Scrutiny: ARIC Analysis

Penumbra Separator 3D: Another Brick in the Wall Supporting Aspiration for Acute Stroke

De-escalating DAPT to a Clopidogrel-Based Strategy After PCI for ACS Gets Boost in TOPIC-VASP

Registry Challenges LVEF Cutoff for AVR, With Implications for Asymptomatic Patients

Ten Principles for Successful Treatment of HF With Reduced EF: New ACC Decision Pathway

The Biggest News of 2017: TCTMD’s Top 10

Current Challenges to and Future Direction of US Early Feasibility Studies FDA Point of View

Role of Interventional Cardiologists in Secondary Prevention of Acute Coronary Syndromes: Redefining Clinical Practice

Tricuspid Valve Therapy & Innovative Clinical Trials: A Comprehensive Discussion

Severe/Resistant Hypercholesterolemia: New Agents Redefining Clinical Practice

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content